The first non-prion pathogen identified: neurotropic influenza virus

References

• Prusiner SB. Prions. Proc Natl Acad Sci U S A. 1998;95(23):13363–13383.
   PubMed Web of Science ®Google Scholar
• DeArmond SJ, Prusiner SB. Etiology and pathogenesis of prion diseases. Am J Pathol. 1995;146(4):785–811.
   PubMed Web of Science ®Google Scholar
• Scheckel C, Aguzzi A. Prions, prionoids and protein misfolding disorders. Nat Rev Genet. 2018;19(7):405–418.
   PubMed Web of Science ®Google Scholar
• Pan KM, Baldwin M, Nguyen J, et al. Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci USA. 1993;90(23):10962–10966.
   PubMed Web of Science ®Google Scholar
• Oesch B, Westaway D, Walchli M, et al. A cellular gene encodes scrapie PrP 27-30 protein. Cell. 1985;40(4):735–746.
   PubMed Web of Science ®Google Scholar
• Prusiner SB. Molecular biology of prion diseases. Science. 1991;252(5012):1515–1522.
   PubMed Web of Science ®Google Scholar
• Hackl S, Becker CFW. Prion protein-Semisynthetic prion protein (PrP) variants with posttranslational modifications. J Pept Sci. 2019;25(10):e3216.
   PubMed Web of Science ®Google Scholar
• Prusiner SB. Biology of prion diseases. J Acquir Immune Defic Syndr. 1993;6(6):663–665.
   PubMed Web of Science ®Google Scholar
• Brandel JP, Peckeu L, Haik S. The French surveillance network of Creutzfeldt-Jakob disease. Epidemiological data in France and worldwide. Transfus Clin Biol. 2013;20(4):395–397.
   PubMed Web of Science ®Google Scholar
• Heinemann U, Krasnianski A, Meer B, et al. Creutzfeldt-Jakob disease in Germany: a prospective 12-year surveillance. Brain. 2007;130(5):1350–1359.
   PubMedGoogle Scholar
• Maddox RA, Person MK, Blevins JE, et al. Prion disease incidence in the United States: 2003-2015. Neurology. 2020;94(2):e153–e7.
   PubMed Web of Science ®Google Scholar
• Webb TE, Poulter M, Beck J, et al. Phenotypic heterogeneity and genetic modification of P102L inherited prion disease in an international series. Brain. 2008;131(10):2632–2646.
   PubMedGoogle Scholar
• Cracco L, Appleby BS, Gambetti P. Fatal familial insomnia and sporadic fatal insomnia. Handb Clin Neurol. 2018;153:271–299.
   PubMedGoogle Scholar
• Will RG, Ironside JW, Zeidler M, et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet. 1996;347(9006):921–925.
   PubMed Web of Science ®Google Scholar
• Will RG. Acquired prion disease: iatrogenic CJD, variant CJD, kuru. Br Med Bull. 2003;66(1):255–265.
   PubMedGoogle Scholar
• Jarrett JT, Lansbury PT Jr. Seeding “one-dimensional crystallization” of amyloid: a pathogenic mechanism in Alzheimer’s disease and scrapie? Cell. 1993;73(6):1055–1058.
   PubMed Web of Science ®Google Scholar
• Kocisko DA, Come JH, Priola SA, et al. Cell-free formation of protease-resistant prion protein. Nature. 1994;370(6489):471–474.
   PubMed Web of Science ®Google Scholar
• Marttila RJ, Rinne UK, Halonen P, et al. Herpesviruses and parkinsonism. Herpes simplex virus types 1 and 2, and cytomegalovirus antibodies in serum and CSF. Arch Neurol. 1981;38(1):19–21.
   Google Scholar
• Vlajinac H, Dzoljic E, Maksimovic J, et al. Infections as a risk factor for Parkinson’s disease: a case-control study. Int J Neurosci. 2013;123(5):329–332.
   PubMed Web of Science ®Google Scholar
• Jang H, Boltz D, Sturm-Ramirez K, et al. Highly pathogenic H5N1 influenza virus can enter the central nervous system and induce neuroinflammation and neurodegeneration. Proc Natl Acad Sci U S A. 2009;106(33):14063–14068.
   PubMed Web of Science ®Google Scholar
• Jamieson GA, Maitland NJ, Wilcock GK, et al. Latent herpes simplex virus type 1 in normal and Alzheimer’s disease brains. J Med Virol. 1991;33(4):224–227.
   PubMed Web of Science ®Google Scholar
• Readhead B, Haure-Mirande J-V, Funk CC, et al. Multiscale Analysis of Independent Alzheimer’s Cohorts Finds Disruption of Molecular, Genetic, and Clinical Networks by Human Herpesvirus. Neuron. 2018;99(1):64–82 e7.
   PubMed Web of Science ®Google Scholar
• Liu S, Hossinger A, Heumuller SE, et al. Highly efficient intercellular spreading of protein misfolding mediated by viral ligand-receptor interactions. Nat Commun. 2021;12(1):5739.
   PubMed Web of Science ®Google Scholar
• Hara H, Chida J, Uchiyama K, et al. Neurotropic influenza A virus infection causes prion protein misfolding into infectious prions in neuroblastoma cells. Sci Rep. 2021;11(1):10109.
   PubMed Web of Science ®Google Scholar
• Butler DA, Scott MR, Bockman JM, et al. Scrapie-infected murine neuroblastoma cells produce protease-resistant prion proteins. J Virol. 1988;62(5):1558–1564.
   PubMed Web of Science ®Google Scholar
• Nishida N, Harris DA, Vilette D, et al. Successful transmission of three mouse-adapted scrapie strains to murine neuroblastoma cell lines overexpressing wild-type mouse prion protein. J Virol. 2000;74(1):320–325.
   PubMed Web of Science ®Google Scholar
• Fujita K, Yamaguchi Y, Mori T, et al. Effects of a brain-engraftable microglial cell line expressing anti-prion scFv antibodies on survival times of mice infected with scrapie prions. Cell Mol Neurobiol. 2011;31(7):999–1008.
   PubMed Web of Science ®Google Scholar
• Ferhadian D, Contrant M, Printz-Schweigert A, et al. Structural and Functional Motifs in Influenza Virus RNAs. Front Microbiol. 2018;9:559.
   PubMed Web of Science ®Google Scholar
• Adler V, Zeiler B, Kryukov V, et al. Small, highly structured RNAs participate in the conversion of human recombinant PrPSen to PrPRes in vitro. J Mol Biol. 2003;332(1):47–57.
   PubMed Web of Science ®Google Scholar
• Wang F, Yang F, Hu Y, et al. Lipid Interaction Converts Prion Protein to a PrPSc-like Proteinase K-Resistant Conformation under Physiological Conditions. Biochemistry. 2007;46(23):7045–7053.
   PubMed Web of Science ®Google Scholar
• Wang F, Wang X, Yuan CG, et al. Generating a prion with bacterially expressed recombinant prion protein. Science. 2010;327(5969):1132–1135.
   PubMed Web of Science ®Google Scholar
• Deleault NR, Lucassen RW, Supattapone S. RNA molecules stimulate prion protein conversion. Nature. 2003;425(6959):717–720.
   PubMed Web of Science ®Google Scholar
• Tetz G, Tetz V. Prion-like Domains in Eukaryotic Viruses. Sci Rep. 2018;8(1):8931.
   PubMedGoogle Scholar
• Haviv Y, Avrahami D, Ovadia H, et al. Induced neuroprotection independently from PrPSc accumulation in a mouse model for prion disease treated with simvastatin. Arch Neurol. 2008;65(6):762–775.
   PubMedGoogle Scholar
• Leblanc P, Alais S, Porto-Carreiro I, et al. Retrovirus infection strongly enhances scrapie infectivity release in cell culture. Embo J. 2006;25 (12):2674–2685.
   PubMed Web of Science ®Google Scholar
• Ehresmann DW, Hogan RN. Acceleration of scrapie disease in mice by an adenovirus. Intervirology. 1986;25(2):103–110.
   PubMed Web of Science ®Google Scholar
• Stanton JB, Knowles DP, O’Rourke KI, et al. Small-Ruminant Lentivirus Enhances PrPSc Accumulation in Cultured Sheep Microglial Cells. J Virol. 2008;82(20):9839–9847.
   PubMed Web of Science ®Google Scholar
• Lins N, Mourao L, Trevia N, et al. Virus Infections on Prion Diseased Mice Exacerbate Inflammatory Microglial Response. Oxid Med Cell Longev. 2016;2016:3974648.
   PubMed Web of Science ®Google Scholar
• Wickner RB, Masison DC, Edskes HK. [PSI] and [URE3] as yeast prions. Yeast. 1995;11(16):1671–1685.
   PubMed Web of Science ®Google Scholar
• True HL, Berlin I, Lindquist SL. Epigenetic regulation of translation reveals hidden genetic variation to produce complex traits. Nature. 2004;431(7005):184–187.
   PubMed Web of Science ®Google Scholar
• True HL, Lindquist SL. A yeast prion provides a mechanism for genetic variation and phenotypic diversity. Nature. 2000;407(6803):477–483.
   PubMed Web of Science ®Google Scholar
• Suzuki G, Shimazu N, Tanaka M. A yeast prion, Mod5, promotes acquired drug resistance and cell survival under environmental stress. Science. 2012;336(6079):355–359.
   PubMed Web of Science ®Google Scholar
• Ruland J. Inflammasome: putting the pieces together. Cell. 2014;156(6):1127–1129.
   PubMed Web of Science ®Google Scholar
• Eimer WA, Vijaya Kumar DK, Navalpur Shanmugam NK, et al. Alzheimer’s Disease-Associated beta-Amyloid Is Rapidly Seeded by Herpesviridae to Protect against Brain Infection. Neuron. 2018;99(1):56–63 e3.
   PubMed Web of Science ®Google Scholar
• Chida J, Hara H, Yano M, et al. Prion protein protects mice from lethal infection with influenza A viruses. PLoS Pathog. 2018;14:e1007049.
   PubMed Web of Science ®Google Scholar
• d’Errico P, Meyer-Luehmann M. Mechanisms of Pathogenic Tau and Abeta Protein Spreading in Alzheimer’s Disease. Front Aging Neurosci. 2020;12:265.
   PubMed Web of Science ®Google Scholar
• Billings LM, Oddo S, Green KN, et al. Intraneuronal Abeta causes the onset of early Alzheimer’s disease-related cognitive deficits in transgenic mice. Neuron. 2005;45(5):675–688.
   PubMed Web of Science ®Google Scholar
• Jellinger KA. Neuropathological aspects of Alzheimer disease, Parkinson disease and frontotemporal dementia. Neurodegener Dis. 2008;5(3–4):118–121.
   PubMed Web of Science ®Google Scholar
• Duda JE, Lee VM, Trojanowski JQ. Neuropathology of synuclein aggregates. J Neurosci Res. 2000;61(2):121–127.
   PubMed Web of Science ®Google Scholar
• Marreiros R, Muller-Schiffmann A, Trossbach SV, et al. Disruption of cellular proteostasis by H1N1 influenza A virus causes alpha-synuclein aggregation. Proc Natl Acad Sci U S A. 2020;117(12):6741–6751.
   PubMed Web of Science ®Google Scholar
• Wozniak MA, Itzhaki RF, Shipley SJ, et al. Herpes simplex virus infection causes cellular beta-amyloid accumulation and secretase upregulation. Neurosci Lett. 2007;429(2–3):95–100.
   PubMed Web of Science ®Google Scholar